Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease

Eduard J. Van Beers, Leigh Samsel, Laurel Mendelsohn, Rehan Saiyed, Kleber Y. Fertrin, Christine A. Brantner, Mathew P. Daniels, James Nichols, J. Philip McCoy, Gregory J. Kato

Research output: Contribution to journalArticle

Abstract

In preclinical and early phase pharmacologic trials in sickle cell disease, the percentage of sickled erythrocytes after deoxygenation, an ex vivo functional sickling assay, has been used as a measure of a patient's disease outcome. We developed a new sickle imaging flow cytometry assay (SIFCA) and investigated its application. To perform the SIFCA, peripheral blood was diluted, deoxygenated (2% oxygen) for 2 hr, fixed, and analyzed using imaging flow cytometry. We developed a software algorithm that correctly classified investigator tagged "sickled" and "normal" erythrocyte morphology with a sensitivity of 100% and a specificity of 99.1%. The percentage of sickled cells as measured by SIFCA correlated strongly with the percentage of sickle cell anemia blood in experimentally admixed samples (R=0.98, P≤0.001), negatively with fetal hemoglobin (HbF) levels (R=-0.558, P=0.027), negatively with pH (R=-0.688, P=0.026), negatively with pretreatment with the antisickling agent, Aes-103 (5-hydroxymethyl-2-furfural) (R=-0.766, P=0.002), and positively with the presence of long intracellular fibers as visualized by transmission electron microscopy (R=0.799, P=0.002). This study shows proof of principle that the automated, operator-independent SIFCA is associated with predictable physiologic and clinical parameters and is altered by the putative antisickling agent, Aes-103. SIFCA is a new method that may be useful in sickle cell drug development.

Original languageEnglish (US)
Pages (from-to)598-603
Number of pages6
JournalAmerican Journal of Hematology
Volume89
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Flow Cytometry
Erythrocytes
Antisickling Agents
Fetal Hemoglobin
Transmission Electron Microscopy
Hypoxia
Software
Research Personnel
Oxygen
Pharmaceutical Preparations
5-hydroxymethylfurfural

ASJC Scopus subject areas

  • Hematology

Cite this

Van Beers, E. J., Samsel, L., Mendelsohn, L., Saiyed, R., Fertrin, K. Y., Brantner, C. A., ... Kato, G. J. (2014). Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. American Journal of Hematology, 89(6), 598-603. https://doi.org/10.1002/ajh.23699

Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. / Van Beers, Eduard J.; Samsel, Leigh; Mendelsohn, Laurel; Saiyed, Rehan; Fertrin, Kleber Y.; Brantner, Christine A.; Daniels, Mathew P.; Nichols, James; McCoy, J. Philip; Kato, Gregory J.

In: American Journal of Hematology, Vol. 89, No. 6, 2014, p. 598-603.

Research output: Contribution to journalArticle

Van Beers, EJ, Samsel, L, Mendelsohn, L, Saiyed, R, Fertrin, KY, Brantner, CA, Daniels, MP, Nichols, J, McCoy, JP & Kato, GJ 2014, 'Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease', American Journal of Hematology, vol. 89, no. 6, pp. 598-603. https://doi.org/10.1002/ajh.23699
Van Beers, Eduard J. ; Samsel, Leigh ; Mendelsohn, Laurel ; Saiyed, Rehan ; Fertrin, Kleber Y. ; Brantner, Christine A. ; Daniels, Mathew P. ; Nichols, James ; McCoy, J. Philip ; Kato, Gregory J. / Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. In: American Journal of Hematology. 2014 ; Vol. 89, No. 6. pp. 598-603.
@article{9ef8d3c3f56e47629ac1b762cca8d243,
title = "Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease",
abstract = "In preclinical and early phase pharmacologic trials in sickle cell disease, the percentage of sickled erythrocytes after deoxygenation, an ex vivo functional sickling assay, has been used as a measure of a patient's disease outcome. We developed a new sickle imaging flow cytometry assay (SIFCA) and investigated its application. To perform the SIFCA, peripheral blood was diluted, deoxygenated (2{\%} oxygen) for 2 hr, fixed, and analyzed using imaging flow cytometry. We developed a software algorithm that correctly classified investigator tagged {"}sickled{"} and {"}normal{"} erythrocyte morphology with a sensitivity of 100{\%} and a specificity of 99.1{\%}. The percentage of sickled cells as measured by SIFCA correlated strongly with the percentage of sickle cell anemia blood in experimentally admixed samples (R=0.98, P≤0.001), negatively with fetal hemoglobin (HbF) levels (R=-0.558, P=0.027), negatively with pH (R=-0.688, P=0.026), negatively with pretreatment with the antisickling agent, Aes-103 (5-hydroxymethyl-2-furfural) (R=-0.766, P=0.002), and positively with the presence of long intracellular fibers as visualized by transmission electron microscopy (R=0.799, P=0.002). This study shows proof of principle that the automated, operator-independent SIFCA is associated with predictable physiologic and clinical parameters and is altered by the putative antisickling agent, Aes-103. SIFCA is a new method that may be useful in sickle cell drug development.",
author = "{Van Beers}, {Eduard J.} and Leigh Samsel and Laurel Mendelsohn and Rehan Saiyed and Fertrin, {Kleber Y.} and Brantner, {Christine A.} and Daniels, {Mathew P.} and James Nichols and McCoy, {J. Philip} and Kato, {Gregory J.}",
year = "2014",
doi = "10.1002/ajh.23699",
language = "English (US)",
volume = "89",
pages = "598--603",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease

AU - Van Beers, Eduard J.

AU - Samsel, Leigh

AU - Mendelsohn, Laurel

AU - Saiyed, Rehan

AU - Fertrin, Kleber Y.

AU - Brantner, Christine A.

AU - Daniels, Mathew P.

AU - Nichols, James

AU - McCoy, J. Philip

AU - Kato, Gregory J.

PY - 2014

Y1 - 2014

N2 - In preclinical and early phase pharmacologic trials in sickle cell disease, the percentage of sickled erythrocytes after deoxygenation, an ex vivo functional sickling assay, has been used as a measure of a patient's disease outcome. We developed a new sickle imaging flow cytometry assay (SIFCA) and investigated its application. To perform the SIFCA, peripheral blood was diluted, deoxygenated (2% oxygen) for 2 hr, fixed, and analyzed using imaging flow cytometry. We developed a software algorithm that correctly classified investigator tagged "sickled" and "normal" erythrocyte morphology with a sensitivity of 100% and a specificity of 99.1%. The percentage of sickled cells as measured by SIFCA correlated strongly with the percentage of sickle cell anemia blood in experimentally admixed samples (R=0.98, P≤0.001), negatively with fetal hemoglobin (HbF) levels (R=-0.558, P=0.027), negatively with pH (R=-0.688, P=0.026), negatively with pretreatment with the antisickling agent, Aes-103 (5-hydroxymethyl-2-furfural) (R=-0.766, P=0.002), and positively with the presence of long intracellular fibers as visualized by transmission electron microscopy (R=0.799, P=0.002). This study shows proof of principle that the automated, operator-independent SIFCA is associated with predictable physiologic and clinical parameters and is altered by the putative antisickling agent, Aes-103. SIFCA is a new method that may be useful in sickle cell drug development.

AB - In preclinical and early phase pharmacologic trials in sickle cell disease, the percentage of sickled erythrocytes after deoxygenation, an ex vivo functional sickling assay, has been used as a measure of a patient's disease outcome. We developed a new sickle imaging flow cytometry assay (SIFCA) and investigated its application. To perform the SIFCA, peripheral blood was diluted, deoxygenated (2% oxygen) for 2 hr, fixed, and analyzed using imaging flow cytometry. We developed a software algorithm that correctly classified investigator tagged "sickled" and "normal" erythrocyte morphology with a sensitivity of 100% and a specificity of 99.1%. The percentage of sickled cells as measured by SIFCA correlated strongly with the percentage of sickle cell anemia blood in experimentally admixed samples (R=0.98, P≤0.001), negatively with fetal hemoglobin (HbF) levels (R=-0.558, P=0.027), negatively with pH (R=-0.688, P=0.026), negatively with pretreatment with the antisickling agent, Aes-103 (5-hydroxymethyl-2-furfural) (R=-0.766, P=0.002), and positively with the presence of long intracellular fibers as visualized by transmission electron microscopy (R=0.799, P=0.002). This study shows proof of principle that the automated, operator-independent SIFCA is associated with predictable physiologic and clinical parameters and is altered by the putative antisickling agent, Aes-103. SIFCA is a new method that may be useful in sickle cell drug development.

UR - http://www.scopus.com/inward/record.url?scp=84900864121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900864121&partnerID=8YFLogxK

U2 - 10.1002/ajh.23699

DO - 10.1002/ajh.23699

M3 - Article

C2 - 24585634

AN - SCOPUS:84900864121

VL - 89

SP - 598

EP - 603

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 6

ER -